Medicine has long been projected to be among the first industries to be heavily impacted by 3D printing technology. After all, hearing aids and dental aligners have proven to be killer apps for the technology, with over 10 million 3D printed hearing aids already in the world today. Now, medical 3D printing has taken a further leap forward via Materialise (MTLS), as the company has received CE Marking Certification for most of its personalized orthopedic and cranio-maxillofacial (CMF) products.
CE Marking approval is meant to demonstrate that a medical device meets that standards of the European Medical Devices Directive. Before this news, Materialise’s 3D printed devices necessitated medical prescriptions each time they were made for every patient and application. Now, the CE Marking applies to a number of products in its portfolio, including patient-specific orthopedics, anatomic models, and patient-specific surgical guides and implants.
Materialise is already a leader in the medical 3D printing space, having produced over 350,000 personalized devices across six continents. The company launched its Mimics software in 1992, forming the foundation for 3D image-based engineering. In 2007, the company was the first to bring 3D printed tools into the operating room with its surgical knee guides. 2009 saw the launch of patient-specific CMF implants, in which part porosity enabled improved bone growth for such devices.
In a recent 3DPrint.com PRO article, executive editor Joris Peels described in detail Materialise’s unique strategy across a number of verticals. Indeed, the Belgian firm has been an interesting one, supplying both software and 3D printing services and now acquiring a 3D scanning firm. Peels suggested that the company has been cautious, yet dependable and innovative in its strategic decision making—not always being the first to a new market application, but ensuring that a new angle in a new field is worthwhile before jumping in and innovating the hell out of it in a very deliberate manner.
“When the European Medical Devices Directive came to place in 1993, the use of personalized devices was exceptional. In the last 30 years, we have advanced 3D planning and printing to scale this technology to a much larger audience. At Materialise, we are talking about thousands of devices delivered worldwide every year. Personalized devices are no longer the exception. This CE marking certification demonstrates that these personalized devices meet the same stringent quality requirements as regular devices, despite the challenges involved to make every device match the specific patient’s anatomy,” says Brigitte de Vet, Vice President and Managing Director of Materialise Medical.
In this case, the company’s steady work in medical 3D printing has allowed it to become possibly the first to receive such certification for such a wide array of devices. Now, patient-specific implants and guides can be deployed at a larger scale more quickly across Europe. Materialise suggests that the certification will improve accessibility to personalized medical devices, as surgeons won’t need to sign a prescription for the devices they order and there will be less paperwork for pharmacists.
Meanwhile, we know that models and devices tailored to patients improve patient outcomes, reduce time in the operating room, and better prepare surgeons for procedures. De Vet spoke to this, saying:
“The advantage of using personalized devices is that they add more predictability into the surgical setting and allow the treatment of any clinical condition, including the most challenging ones. Now having this CE marking for our larger portfolio will help bring these personalized devices to even more patients, removing some of the administrative constraints for our customers.”
The company already has CE markings for some of its medical software, including Mimics Innovation Suite and Mimics Enlight. Now that it has this certification, we really may see medical 3D printing take off and deliver the value that it has promised for so long. To learn more about the man behind Materialise, listen to our interviews with CEO Fried Vancraen, part one and part two.
(Image courtesy of Materialise.)
You May Also Like
3D Printed Injection Molding and Anisotropy Targeted by Covestro
Upon acquiring the Functional Materials unit of Royal DSM, Covestro has been busy developing new 3D printing materials for a variety of applications. These range from TPU for insoles to...
3D Printing Innovator’s Roundtable Webinar: Ditching DfAM and Embracing Design Freedom
In an industry where change is constant and unpredictable, professionals across the manufacturing industry have turned to additive manufacturing (AM) to overcome design and supply chain challenges. But conventional AM...
3D Printing News Briefs, September 11, 2021: Rocket Nozzles, Ghost Guns, & More
In today’s 3D Printing News Briefs, Stratasys is the first founding partner of nFrontier’s Emerging Technologies Center in Berlin, which is looking to become one of Europe’s top facilities of...
3D Printing Webinar and Event Roundup: September 5, 2021
Buckle up, it’s a busy week of webinars and events ahead! From oxygen content in titanium grades and 3D printed orthotics and prosthetics to saving money in the GrabCAD Shop...
View our broad assortment of in house and third party products.